Financhill

Annual Reports

Per Page: 24
Company
Score
Last Price
Annual Revenues
Last Price:
127.88
Annual Revenues:
6.83B
Return on Equity:
22.07%
Last Price:
32.42
Annual Revenues:
19.11B
Return on Equity:
2.33%
Last Price:
8.07
Annual Revenues:
19.11B
Return on Equity:
2.33%
Last Price:
193.50
Annual Revenues:
383.29B
Return on Equity:
166.1%
Last Price:
13.61
Annual Revenues:
8.21B
Return on Equity:
11.1%
Last Price:
40.39
Annual Revenues:
29.45B
Return on Equity:
31.48%
Last Price:
144.57
Annual Revenues:
58.05B
Return on Equity:
45.56%
Last Price:
2.87
Annual Revenues:
15.46B
Return on Equity:
17.56%
Last Price:
39.80
Annual Revenues:
29.45B
Return on Equity:
31.48%
Last Price:
133.75
Annual Revenues:
8.4B
Return on Equity:
89.29%
Last Price:
104.35
Annual Revenues:
43.65B
Return on Equity:
14.03%
Last Price:
23.68
Annual Revenues:
14.31B
Return on Equity:
0.23%
Last Price:
0.37
Annual Revenues:
107.9B
Return on Equity:
10.29%
Last Price:
8.93
Annual Revenues:
107.9B
Return on Equity:
10.29%
Last Price:
81.85
Annual Revenues:
9.66B
Return on Equity:
23.04%
Last Price:
21.79
Annual Revenues:
77.65B
Return on Equity:
62.12%
Last Price:
90.63
Annual Revenues:
14.38B
Return on Equity:
2.25%
Last Price:
335.83
Annual Revenues:
64.11B
Return on Equity:
28.66%
Last Price:
602.22
Annual Revenues:
17.61B
Return on Equity:
34.96%
Last Price:
105.41
Annual Revenues:
23.74B
Return on Equity:
-2.21%
Last Price:
10.25
Annual Revenues:
1.73B
Return on Equity:
-18.68%
Last Price:
180.63
Annual Revenues:
12.31B
Return on Equity:
9.18%
Last Price:
74.14
Annual Revenues:
101.56B
Return on Equity:
15.96%
No results

Investing News

1 Pharma Stock Insiders Are Scooping Up

1 Pharma Stock Insiders Are Scooping Up

Bristol Myers Squibb (NYSE:BMY) is a biopharma stock that most investors have heard of but few understand well. It also seems to be a stock that many have forgotten about because it’s looking very attractive from a valuation standpoint now. Down 30.3% this year represents a stunning underperformance when compared to the S&P 500 that […]

Read Article

Is Splunk Stock Undervalued?

Is Splunk Stock Undervalued?

Shares of cloud tech company Splunk (NASDAQ:SPLK) are up more than 75% year-to-date, handily outperforming the S&P 500’s average return of 19%. Much of this gain occurred when the stock spiked following the company’s Q3 earnings report, giving existing shareholders a very healthy return on their money. The question now, though, is whether Splunk stock […]

Read Article

How Did Andrew Ross Sorkin Make His Money?

How Did Andrew Ross Sorkin Make His Money?

Andrew Ross Sorkin began his career as a journalist before he graduated from high school. During his senior year, he worked as an intern at The New York Times. He continued working for the paper throughout his education at Cornell University. By the time he graduated, he had published over 70 articles.  After completing his degree […]

Read Article

PetMed Express Eyes Brighter Future

PetMed Express Eyes Brighter Future

Down 56.9% so far this year, online pet pharmacy PetMed Express (NASDAQ:PETS) has really caused its shareholders a lot of heartache. Such drastic selloffs often create opportunities for value investors to buy stocks on sale, so is that the case with PETS share price or is the worst yet to come? Sales Sliding Downhill But […]

Read Article

Billion Dollar Fund Bet 29.1% On 1 Stock

Billion Dollar Fund Bet 29.1% On 1 Stock

Among the most extraordinary investments of the last decade has been Berkshire Hathaway’s bet on Apple. Not because Buffett historically had shied away from technology or anything peculiar to Tim Cook’s firm, but more so because of the size of the bet. The Cupertino-headquartered firm now represents a full 50% of his equity portfolio. For […]

Read Article

When Does Gold Go Up?

When Does Gold Go Up?

Gold prices over the past month have been on a tear, up 3.91% but for the year the return enjoyed by goldbugs has paled in comparison to the market. The S&P 500 is up 20.15% whereas gold has climbed by just 12.25%. Speculation is growing that the precious metal is on the cusp of breaking […]

Read Article

More Investing News

The #1 Stock Analysis Tool to Make Smarter Buy and Sell Decisions

Get started at Financhill, the #1 investment research platform that is your one-stop shop for finding the best trade ideas today.

  • Top Rated Stock Ideas
    Financhill Stock Score is a proprietary stock rating engine that independently evaluates every company based on fundamental, technical, and sentiment criteria so you can find the highest rated stocks in the S&P 500, NASDAQ and NYSE.
  • Best Stock Tools Platform
    Whether you are looking for the best blue chip stocks, top dividend stocks, most shorted stocks, cheapest stocks today, highest dividend stocks or best stocks under $50, Financhill has got you covered and has so much more.
  • Stocks Set To Soar & Crash
    Financhill spots seasonal patterns in thousands of stocks so you can easily screen for the best stocks at this time of year. Want to know what stocks could rise 11% over the next 7 weeks with 91% accuracy based on past history? Our Seasonality Screener will surface the hottest stocks right now.
Learn More

Featured in:

CNBC
The Wall Street Journal
Chicago Tribune
Barrons
MSN
Reuters